Policy and Regulatory

fda-highlights-associated-risks-of-herbal-medicine-kratom
Image credit- freedomfromaddiction.com

FDA highlights associated risks of herbal medicine Kratom

Kratom contains alkaloids mitragynine and 7-hydroxymitragynine that have similar effects as opioids. The United States Food and Drugs Administration (FDA) has raised the issue about the potential safety risks associated with the botanical substance, Kratom. Kratom grows naturally in several Southeast Asian countries such as Thailand, Malaysia, Indonesia and Papua[Read More…]

Read More
 
 

Follow us

Let's connect on any of these social networks!